Automated external defibrillators (AEDs) are portable and lightweight electronic device that deliver electric shock to the heart through chest. AEDs determine the cardiac arrhythmia and ventricular tachycardia and treat them with defibrillation to resume normal rhythm. AEDs are vital in treating sudden cardiac arrest (SCA), which is a result of ventricular fibrillations and ventricular tachycardia. According to America Heart Association (AHA), SCA is a leading cause of death globally, accounting for more than 350,000 medical emergencies every year in the U.S. alone. Factors such as growing government initiatives regarding public access defibrillators (PAD) programs, leading to setup of defibrillators in the populated public places would drive the demand for automated external defibrillators. Growing prevalence of cardiac diseases, rising geriatric population and technological advancements in the defibrillators technologies would further fuel the automated external defibrillators market.
The aforementioned report, titled “Automated External Defibrillators Market – Growth, Future Prospects and Competitive Analysis, 2021-2029” delivers competitive market insights of the overall automated external defibrillators industry. This report version proposes to present market size and forecast of the global automated external defibrillators market for the period of 2019-2019 with forecast duration from 2021-2029. The market is segmented in terms of defibrillators type and different geographies and country analysis.
In terms of product types, the market is categorized into semi-automated external defibrillators and fully automatic external defibrillators. On the basis of geographical segmentation, the market was studied across North America (Canada and U.S.), Europe (Germany, U.K., and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Mexico, Brazil, and Rest of Latin America) and Middle East and Africa (GCC and Rest of Middle East and Africa). Market estimation for each region and country is analyzed for the focus period of 2019 to 2029, with forecast from 2021 to 2029 considering 2020 as the base year.
To study the market competition scenario, market positioning and company profile analysis of leading players operating in the global automated external defibrillators market have been provided in the report. The parameters considered for mapping the leading companies were based of business overview, financial analysis, product portfolio and key developments in the company pertaining to the automated external defibrillators industry.
Qualitative assessment of the market was done by monitoring the market drivers, market restraints and market opportunities to get a hold on current market dynamics and to determine the future trend of the automated external defibrillators market. The report also comprises analysis in terms of most attractive investment proposition for regional markets, and business strategies undertaken by companies such as mergers, acquisitions and major collaboration to deliver competitive landscape of the players in the market that would help decision makers in the automated external defibrillators market.
Thus, the aforementioned study provides a comprehensive view of market trends and future opportunities in the global automated external defibrillators market. The major players operating in the market include Boston Scientific, Nihon Kohden Corporation, Philips Healthcare, Zoll Medical, Biotronik, GE Heathcare, St. Jude Medical, Mindray Medical International Limited, Schiller AG and others.
The portability and easy-to-use nature of AEDs makes it possible for nonmedical users to respond to a medical emergency where defibrillation is required. AEDs analyze irregular heartbeats and prompts the delivery of shock when required. Fully automated external defibrillators delivers the shock automatically, analyzing the cardiac rhythm. Rising cases of cardiac diseases globally and launch of technologically advanced defibrillators are the prime drivers for the growth of automated externals defibrillators market. Moreover, growing government initiatives across North America and Europe for establishment of public access defibrillators (PAD) programs would additionally drive the automated external defibrillators market. However, AEDs can only treat ventricular fibrillations and ventricular tachycardia and no other forms for cardiac arrhythmia. AEDs also take significant time to detect cardiac rhythm abnormality compared to manual units which acts as drawbacks of the automated external defibrillators market.
In the year 2020, North America held the largest share in the global automated external defibrillators market due to growing cases of cardiac diseases in the region. Heart diseases are the leading cause of death in the U.S., with more than 610,000 people succumbing to death every year. According to the Centers for Disease Control and Prevention (CDC), atrial fibrillation is the most common type of heart arrhythmia affecting an approximately 2.7 to 6.1 million people in the U.S in 2019 which is said to increase due to rising geriatric population in the country. Moreover, growing government focus on public access defibrillators (PAD) initiatives in the region would further drive the market during the forecast period. Asia Pacific emerged as the fastest growing regional segment in the global automated external defibrillators market due to technologically advanced defibrillators entering the Asia Pacific market, growing prevalence of target diseases and rise in the geriatric population fuelling the market growth in Asia Pacific.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Automated External Defibrillators market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Defibrillator
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
